Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Trading 07-01 10:47:14 EDT

160.64

+10.61

+7.07%

High162.74	Low156.16	Vol1.95M
Open160.76	D1 Closing150.03	Amplitude4.39%
Mkt Cap21.30B	Tradable Cap20.40B	Total Shares132.57M
T/O311.11M	T/O Rate1.53%	Tradable Shares127.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":160.64,"timestamp":1782917234170,"preClose":150.03,"halted":0,"volume":1948642,"delay":0,"changeRate":0.07071918949543415,"floatShares":127000000,"shares":132573424,"eps":-3.404949,"marketStatus":"Trading","change":10.61,"latestTime":"07-01 10:47:14 EDT","open":160.755,"high":162.74,"low":156.16,"amount":311111120.5347,"amplitude":0.043858,"askPrice":160.79,"askSize":5,"bidPrice":160.53,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.404949,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1782936000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":150.03,"preHourTrading":{"tag":"盘前","latestPrice":160,"preClose":150.03,"latestTime":"09:29 EDT","volume":11734,"amount":1832175.62564,"timestamp":1782912599999,"change":9.97,"changeRate":0.066453,"amplitude":0.099313},"postHourTrading":{"tag":"盘后","latestPrice":148.47,"preClose":150.03,"latestTime":"19:43 EDT","volume":312573,"amount":46896011.3325,"timestamp":1782863003888,"change":-1.56,"changeRate":-0.010398,"amplitude":0.020371},"volumeRatio":1.557057,"impliedVol":0.6119,"impliedVolPercentile":0.4741},"requestUrl":"/m/hq/s/GH/wiki","defaultTab":"wiki","newsList":[{"id":"1165344851","title":"Movement Alert｜Guardant Health Rises 7.47% in Regular Trading, Bernstein Sees Revenue Upside From ADLT Pricing Qualification","url":"https://stock-news.laohu8.com/highlight/detail?id=1165344851","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165344851?lang=en_us&edition=fundamental","pubTime":"2026-07-01 22:01","pubTimestamp":1782914518,"startTime":"0","endTime":"0","summary":"On July 1, Guardant Health rose 7.47% in regular trading, trading at $161.43/share, with turnover of $204 million. The rally was driven by a bullish research note from Bernstein highlighting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170394378","title":"Movement Alert｜Guardant Health Pre-Market Rise 5.35%, Bernstein Sees Revenue Upside From ADLT Pricing Qualification","url":"https://stock-news.laohu8.com/highlight/detail?id=1170394378","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170394378?lang=en_us&edition=fundamental","pubTime":"2026-07-01 21:23","pubTimestamp":1782912239,"startTime":"0","endTime":"0","summary":"On July 1, Guardant Health rose 5.35% in pre-market trading, trading near $158.05/share with turnover of approximately $672,000. The rally was driven by a bullish initiation from Bernstein.Bernstein...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648567827","title":"Guardant Health Co-ceo Amirali Talasaz Reports Disposal of Common Shares Worth $39.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2648567827","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648567827?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:14","pubTimestamp":1782854077,"startTime":"0","endTime":"0","summary":"Guardant Health Co-CEO AmirAli Talasaz reports disposal of common shares worth $39.15 millionGuardant Health co-CEO AmirAli Talasaz reported option exercises totaling 254,832 shares on June 26-29 at U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL6zp2fs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Co-ceo Amirali Talasaz Reports Disposal of Common Shares Worth $39.15 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GH","BK4551","BK4535","LU0320765992.SGD","BK4585","LU0109394709.USD","LU0889565916.HKD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648561007","title":"Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2648561007","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648561007?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:05","pubTimestamp":1782849900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, June  30, 2026  (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026 after","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/30/3320099/0/en/Crinetics-Pharmaceuticals-to-Report-Second-Quarter-2026-Financial-Results-on-August-4-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4551","GH","LU0109394709.USD","LU0889565916.HKD","BK4190","BK4196","BK4585","PTH","BK4535","LU0320765992.SGD","BK4204","HERE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647737742","title":"Guardant Health is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2647737742","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647737742?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:08","pubTimestamp":1782742080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJune 29, 2026 10:08 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4551","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4585","BK4535","BK4196","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111761481","title":"Movement Alert｜Guardant Health Rises 5.08% in Regular Trading, Multiple Catalysts Continue to Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1111761481","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111761481?lang=en_us&edition=fundamental","pubTime":"2026-06-27 00:37","pubTimestamp":1782491865,"startTime":"0","endTime":"0","summary":"On June 27, Guardant Health rose 5.08% in regular trading, trading at $150.28/share, with turnover of $177 million. The stock continued its upward trajectory as multiple positive catalysts...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646350157","title":"Guardant Health Price Target Announced at $175.00/share by Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2646350157","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646350157?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:14","pubTimestamp":1782479640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJune 26, 2026 09:14 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0320765992.SGD","GH","BK4588","LU0109394709.USD","BK4551","LU0889565916.HKD","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646352668","title":"GH Research Shareholders Approve Director Slate and 2026 Auditor at June AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2646352668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646352668?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:57","pubTimestamp":1782475054,"startTime":"0","endTime":"0","summary":"GH Research ( ($GHRS) ) just unveiled an announcement. On June 25, 2026, GH Research PLC held its annual general meeting, where shareholders approv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gh-research-shareholders-approve-director-slate-and-2026-auditor-at-june-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gh-research-shareholders-approve-director-slate-and-2026-auditor-at-june-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4195","BK4196","BK4551","LU0109394709.USD","LU0889565916.HKD","GH","BK4229","BK4535","BK4588","LU0320765992.SGD","BK4585","AGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646133434","title":"U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646133434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646133434?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:06","pubTimestamp":1782457590,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-American Tower, H.B. Fuller Company, TD SynnexJune 26 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4N42Y0ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMT","AVXX","AIT","DAL","ALK","DRI","CROX","LU0477156953.USD","LU2413666699.HKD","EXPD","FDXF","ACNB","CUZ","ESTC","CALY","AMAT","CMC","ACA","ALLY","AAL","AR","A","BHVN","BAC","CTSH","LU0648001328.SGD","CNTB","LU0011850046.USD","EPR","GOLF","BDC","AVTR","CSX","FTH","BNY","SNX","TECH","DYN","AVAV","BNED","LU0347712357.USD","AALG","ESS","ALGT","AMH","IE00BD4GTW91.USD","GH","BRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159506789","title":"Movement Alert｜Guardant Health Rises 5.05% in Regular Trading, Multiple Catalysts Drive Continued Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1159506789","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159506789?lang=en_us&edition=fundamental","pubTime":"2026-06-25 22:31","pubTimestamp":1782397901,"startTime":"0","endTime":"0","summary":"On June 25, Guardant Health rose 5.05% in regular trading, trading at 143.47 USD/share, with turnover of $79.42 million. The stock continued its upward momentum driven by a convergence of positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645811531","title":"Guardant Health is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2645811531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645811531?lang=en_us&edition=fundamental","pubTime":"2026-06-24 22:47","pubTimestamp":1782312420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 10:47 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4588","BK4585","GH","LU0320765992.SGD","LU0889565916.HKD","BK4535","BK4551","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645821896","title":"Guardant Health price target raised to $150 from $120 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2645821896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645821896?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:55","pubTimestamp":1782291346,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Guardant Health (GH) to $150 from $120 and keeps an Overweight rating on the shares. The firm adjusted t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-150-from-120-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-150-from-120-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","GH","BK4196","BK4585","BK4551","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645854206","title":"Guardant Health director Myrtle S. Potter disposes of 1,556 common shares worth $204,084.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2645854206","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645854206?lang=en_us&edition=fundamental","pubTime":"2026-06-24 05:29","pubTimestamp":1782250163,"startTime":"0","endTime":"0","summary":"Guardant Health director Myrtle S. Potter sold 1,556 common shares on June 22, 2026 at USD 131.16.Potter held 20,971 common shares following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL9jsQJm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health director Myrtle S. Potter disposes of 1,556 common shares worth $204,084.96","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GH","BK4588","BK4551","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883025","title":"Hikma joins Guardant Health as platinum sponsor at UAE International Oncology Forum IOF 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883025","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645883025?lang=en_us&edition=fundamental","pubTime":"2026-06-22 17:57","pubTimestamp":1782122238,"startTime":"0","endTime":"0","summary":"Hikma attended the 5th Annual International Oncology Forum IOF 2026 in the UAE as a platinum sponsor alongside Guardant Health.Hikma highlighted FDA clearance of Guardant360 Liquid CDx, positioning it to expand precision oncology diagnostics across MENA under its 2024 exclusive deal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hikma Pharmaceuticals plc published the original content used to generate this news brief on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLb4S7kY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","IE00B0JY6N72.USD","HIK.UK","GH","BK5011","BK4588","BK4535","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644361930","title":"Guardant Health shareholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644361930","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644361930?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:12","pubTimestamp":1781813535,"startTime":"0","endTime":"0","summary":"Guardant Health held its annual shareholder meeting on June 17, 2026.An advisory resolution on executive pay failed to pass.Investors supported holding future advisory votes on executive pay every year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL12RmWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4585","BK4588","GH","BK4551","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644380030","title":"Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644380030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644380030?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:15","pubTimestamp":1781806500,"startTime":"0","endTime":"0","summary":"Health is wealth goes the saying. Now it's an investment opportunity, too.The consumerization of healthcare is nothing new, but the pandemic turbocharged its widespread adoption. From telehealth appointments to digital patient portals and wearable trackers, many people began to treat their health like any other retail experience -- whether it's walking into a CVS Health MinuteClinic after doing some shopping, or trying  to estimate the out-of-pocket price for procedures with cost-estimator tools.The upshot is that longevity, i.e. not only living longer but being healthy for longer, could be big business for healthcare companies. TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion, with beneficiaries spanning companies making biological breakthroughs to those using artificial intelligence.\"Tools to measure and screen health status--across blood-based testing, imaging, and wearable--have advanced meaningfully,\" writes lead analyst Da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","LU1699723380.USD","BK4504","LU2112291526.USD","LU0061475181.USD","LU2095319765.USD","LU2065169927.USD","BFLY","BK4007","LU1721429402.USD","LU0006061336.USD","MYGN","LU1064131342.USD","BK4588","LU0114720955.EUR","SGXZ23171101.USD","LU2065171311.SGD","SGXZ41872573.SGD","LU2065170008.USD","OWLT","LU0208291251.USD","LU0211331839.USD","BK4533","HIMZ","LU0170899867.USD","IE0002270589.USD","LU2065171402.SGD","BK4585","SG9999004303.SGD","LU2264538146.SGD","LU0345770308.USD","LU0053671581.USD","BK4167","HMYY","BK4581","BK4082","IE0009355771.USD","BK4566","LU0234572021.USD","BK4551","BTMD","LU0868494617.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0012050646.USD","LU1057294990.SGD","LU2468319806.SGD","LU1323610961.USD","IE00BMPRXR70.SGD","QTRX","IE00B4R5TH58.HKD","BK4209","LU1988902786.USD","LU0963586101.USD","LU2089984988.USD","BK4196","HIYY","LU0882574055.USD","LU1914381329.SGD","LU2433249047.HKD","TDOC","LU1721429741.USD","LU0072461881.USD","LU0354030511.USD","IE0002141913.USD","LU0345770993.USD","BK4568","IE00BFTCPJ56.SGD","LU1923622614.USD","HIMS","LU2133065610.SGD","GB00BDT5M118.USD","LU0058720904.USD","LU0354030438.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","BK4139","SG9999002232.USD","LU1983299246.USD","BK4592","LU2324357040.USD","LU2065731478.USD","BK4567","LU2210149790.SGD","LU0320765489.SGD","LU1571399168.USD","LU1989763690.USD","LU1861558580.USD","IE00B2B36J28.USD","LU2125909247.SGD","ABT","LU0122379950.USD","LU1691799644.USD","SG9999002224.SGD","IE00B19Z3581.USD","BK4121","BK4216","LU2211815571.USD","LU2125909593.SGD","IE00BMPRXN33.USD","LU1989763427.SGD","LU0162691827.USD","BK4535","IE00B19Z3B42.SGD","LU0266013472.USD","CAVA","BK4534","LU2210150020.SGD","IE00BKVL7J92.USD","HIMY","LU1059921491.USD","GH","LU0070302665.USD","LU1861559042.SGD","PLNT","IE00B7SZLL34.SGD","IE00BJJMRZ35.SGD","BK4548","BK4550","DXCM","CVS","LU1023059063.AUD","LU0390134368.USD","LU0432979614.USD","LU2237957902.USD","NTRA","IE00BSNM7G36.USD","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644727716","title":"What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2644727716","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644727716?lang=en_us&edition=fundamental","pubTime":"2026-06-18 06:24","pubTimestamp":1781735050,"startTime":"0","endTime":"0","summary":"Earlier in June 2026, GH Research PLC reported full Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all 10 patients, improved maternal functioning, and a favorable safety profile, with findings published in The Journal of Clinical Psychiatry and highlighted at the upcoming CINP 2026 congress.\nAn additional practical insight from the trial was that drug levels in breast milk supported only a brief interruption of breastfeeding around...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/what-gh-research-ghrss-phase-2a-postpartum-depression-breakt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/what-gh-research-ghrss-phase-2a-postpartum-depression-breakt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","BK4539","GHRS","GH","BK4535","BK4585","BK4551","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644748410","title":"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BridgeBio Pharma (BBIO) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644748410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644748410?lang=en_us&edition=fundamental","pubTime":"2026-06-17 18:50","pubTimestamp":1781693443,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on IQVIA Holdings (IQV), BridgeBio Pharma (BBIO) and Guardant Health...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-bridgebio-pharma-bbio-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-bridgebio-pharma-bbio-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LU1989764664.SGD","LU0130518102.USD","LU0648000940.SGD","LU0198837287.USD","LU1989764748.USD","BBIO","BK4530","GH","LU0477156953.USD","LU0029874061.USD","IQV","BK4137","LU0130517989.USD","BK4121","LU0477156797.USD","LU0980610538.SGD","LU1791710582.SGD","BK4139","LU0130103400.USD","BK4505","BK4535","LU0130102774.USD","BK4581","HCSG","BK4196","LU0882574055.USD","XLV","LU0528227936.USD","LU0648001328.SGD","LU1261432733.SGD","LU1201861249.SGD","LU1791710400.SGD","BK4588","LU1201861165.SGD","LU0128526141.USD","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644715008","title":"U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715008","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644715008?lang=en_us&edition=fundamental","pubTime":"2026-06-17 15:16","pubTimestamp":1781680605,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, WelltowerJune 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CF","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nL4N42P0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAT","XRN","HUN","LU0158827781.USD","CTRE","HUMA","LU2065731478.USD","GKOS","KLAC","LU2360032135.SGD","DDOG","LDOS","AMH","R","ARWR","VMI","AMAT","SBRA","VTR","COAG","MATX","FIG","JAN","LU2298064838.USD","CNK","LRCX","LSTR","CF","JBHT","FDX","HR","GRDN","IONS","INVH","WELL","AIZ","CRI","FIGG","OHI","CMI","SNDR","DOGD","CTSH","LRCU","LU0011850046.USD","KLAG","DOC","KMB","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644797034","title":"Guardant Health Inc : Jefferies Raises Target Price to $150 From $130","url":"https://stock-news.laohu8.com/highlight/detail?id=2644797034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644797034?lang=en_us&edition=fundamental","pubTime":"2026-06-17 12:00","pubTimestamp":1781668839,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42O0SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GH","BK4535","BK4196","BK4588","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":0.1468},{"period":"1month","weight":0.1568},{"period":"3month","weight":0.646},{"period":"6month","weight":0.4689},{"period":"1year","weight":1.883},{"period":"ytd","weight":0.4689}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.1397},{"period":"6month","weight":0.0951},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022604},{"month":5,"riseRate":0.625,"avgChangeRate":0.118443},{"month":6,"riseRate":0.75,"avgChangeRate":0.091261},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction